Effect of Intravenous Nicorandil in Patients With Primary PTCA : Assessment of Viability and Regional Wall Motion With ^<99m>Tc-Tetrofosmin Quantitative-gated SPECT

  • Imuro Yusuke
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Nakamura Seishi
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Nishiue Takashi
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Hatada Kengo
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Kurihara Hirohiko
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Kawamura Akihiro
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Matsumoto Noriko
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Iwasaki Masayoshi
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Yuyama Reisuke
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Komatsu Kaori
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Haiden Mio
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Mimura Jun
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Iharada Yoshiji
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Saito Daiki
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Miyoshi Hironori
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Kamihata Hiroshi
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Takehana Kazuya
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Iwasaka Toshiji
    Cardiovascular Division of Internal Medicine II, Kansai Medical University
  • Sugiura Tetsurou
    Kochi Medical College
  • Hamada Shinichi
    Fukui Red-cross Hospital

この論文をさがす

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ